Support- professional: expert witness
Ended Purchase Order Awarded Last action
- Contract number
- 15DDHQ25P00000423
- Awardee
-
Gene S. Kennedy, M.d., P.C. UEI PXMMFWNTQXF3
- Awarding agency
-
Drug Enforcement Administration
Department of Justice
- Obligated
- $9,750
Award facts
- Contract value 95% obligated
-
- $9,750.00 Current, with exercised options
- $10,250.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 621111 Offices of Physicians (except Mental Health Specialists)
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Labor Hours
- Place of performance
- St Simons Island, GA 31522, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$500 | |
| Original award | $10,250 |
About this award
The Drug Enforcement Administration (DEA) awarded a $10.25K purchase order contract to Gene S. Kennedy, M.D., P.C. for medical records expert review services. The contract, effective April 28, 2025, through April 27, 2026, with an ultimate completion date of May 25, 2026, represents a continuation of the vendor's specialized support to federal law enforcement. The work will be performed at the contractor's location in St. Simons Island, Georgia. No small business or veteran-owned set-aside designation was applied to this award, consistent with the company's status as a prime contractor providing highly specialized professional services. The contract is structured on a labor-hours basis, reflecting the expert-level nature of the engagement.
Gene S. Kennedy, M.D., P.C., a for-profit, veteran-owned small business medical practice, specializes in providing expert medical consulting and witness services to federal agencies with particular expertise in controlled substance investigations and pharmaceutical regulatory compliance. The contractor delivers services including Prescription Drug Monitoring Program analysis, medical record reviews, patient file assessments, and expert testimony supporting DEA investigations into controlled substance diversion and prescribing practice violations. This award represents part of an extensive series of federal contracts the vendor has received since 2021, exclusively from the DEA and U.S. Attorney's Offices, establishing the practice as a critical subject matter expert resource for federal pharmaceutical enforcement operations. No subcontractors are identified on this award.
Quick answers
Who was awarded contract 15DDHQ25P00000423?
15DDHQ25P00000423 was awarded to Gene S. Kennedy, M.d., P.C. by Drug Enforcement Administration (Department of Justice) on May 26, 2025.
How much is contract 15DDHQ25P00000423 worth?
The government has obligated $9,750 on 15DDHQ25P00000423. Its potential value, with all options, is $10,250.
Was contract 15DDHQ25P00000423 competed?
The extent of competition for 15DDHQ25P00000423 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award